名稱(chēng) | CCDC6-RET WT/BaF3 |
型號(hào) | CBP73214 |
報(bào)價(jià) | ![]() |
特點(diǎn) | CCDC6-RET WT/BaF3,母細(xì)胞:BaF3 |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 實(shí)驗(yàn)?zāi)芊裰貜?fù)仍在持續(xù):誰(shuí)來(lái)給韓春雨事件畫(huà)上句號(hào)?
- 腫瘤細(xì)胞的熱敏感特性分析
- JCI:華人科學(xué)家發(fā)現(xiàn)促進(jìn)乳腺癌進(jìn)展轉(zhuǎn)移的表觀(guān)修飾閱讀者
- 有關(guān)細(xì)胞株生長(zhǎng)要考慮的因素
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- IL27細(xì)胞篩選模型
- 【藥靶模型】ESR1 Y537S模型開(kāi)發(fā)
- 【新品上線(xiàn)】一種安全高效的中和抗體體外篩選模型
- 選擇進(jìn)口的細(xì)胞株這幾點(diǎn)千萬(wàn)不能忘!
- 【連載-Toll樣受體系列2】TLR7激動(dòng)劑藥物細(xì)胞篩選模型
聯(lián)系我們
電話(huà):4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73214CCDC6-RET WT/BaF3

- 詳細(xì)內(nèi)容
CBP73214 | |
I. Introduction | |
Cell Line Name: | CCDC6-RET WT/BaF3 |
Host Cell: | BA/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin |
Mycoplasma Status: | Negative |
II.Background | |
CCDC6, coiled-coil domain containing 6, has been shown to play a role in the DNA damaging signaling pathway acting as a substrate of ATM (PMID: 17420723). CCDC6 fusions with RET (PMID: 23154560, PMID: 26078337) and BRAF (PMID: 26314551) have been observed in multiple cancer types. | |
III. Representative Data | |
1. WB of CCDC6-RET WT/BaF3WT | |
2. Sanger of CCDC6-RET WT/BaF3 Figure 2. Breakpoint of CCDC6-RET WT/BaF3 | |
2. Anti-proliferation assay | |
Figure 3. CTG assay of for CCDC6-RET WT/BaF3 Stable Cell Line,the Gi50 was 137.3nM. |